Company: BDRX
Filing Date: 2025-01-21
Form Type: 424B3
Source: 0001214659-25-000936
Chunk: 45

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-01-21
Form: 424B3
Chunk 45
---
 every Fixed Purchase Notice, VWAP Purchase Notice and/or Additional VWAP
Purchase Notice (each a “”). In the event that the Company fails to pay the applicable portion
of the Commitment Fee to the Investor on the relevant Commitment Fee Payment Date, the Company shall have the right, at the Company’s
discretion, to issue Depositary Shares representing the value of the applicable portion of the Commitment Fee in the aggregate (valued
at the closing sale price for the Depositary Shares on the Primary Market on the Business Day immediately prior to the Execution Date)
(collectively, the “”) to release the Company of its liability to pay such portion of the Commitment
Fee to the Investor as a liquidated sum, which shall be issued by the Company to the Investor within five (5) Business Days after the
relevant Commitment Fee Payment Date (any Commitment Shares that are issued in respect of the Initial Commitment Fee are herein referred
to as the “”). Upon any issuance of Commitment Shares, the Company shall deliver to the Depositary
a Depositary Instruction Letter (as defined herein) with respect to the issuance of such Commitment Shares. For the avoidance of doubt,
(i) no payment is due by the Investor for any Commitment Shares, if any, issued to it by the Company pursuant to the terms of this Agreement
to release the Company of its liability to pay the Commitment Fee, and (ii) any remaining amount of the Commitment Fee shall be payable
by the Company to the Investor in cash in immediately available funds to an account designated by the Investor upon the termination of
this Agreement (the Company shall have the right, at the Company’s discretion, to issue Commitment Shares to the Investor to release
the Company of its liability to pay such remaining amount).

| -23- |

(f) . The Investor shall have the right, from time to time as the Investor may reasonably deem appropriate,
to perform reasonable due diligence on the Company during normal business hours upon three (3) Business Days’ prior written notice.
The Company and its officers and employees shall provide material information and reasonably cooperate with the Investor in connection
with any reasonable request by the Investor related to the Investor’s due diligence of the Company. Each party hereto agrees not
to disclose any Confidential Information of the other party to any third party and shall not use the Confidential Information for any
purpose other than in connection with, or in furtherance of, the transactions contemplated hereby. Each party hereto acknowledges that